These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4422945)

  • 21. [Treatment of essential hypertension with spironolactone with reference to the plasma renin activity].
    Esch I; Placheta P
    Wien Klin Wochenschr; 1973 Jun; 85(23):413-7. PubMed ID: 4575841
    [No Abstract]   [Full Text] [Related]  

  • 22. [Variations of renin activity in hypertensive patients under aldactone therapy].
    Popov NG; Kiprov D; Astrug A; Dotschev D
    Med Welt; 1971 Jul; 22(29):1207-9. PubMed ID: 5566156
    [No Abstract]   [Full Text] [Related]  

  • 23. [Plasmatic renin activity in essential arterial hypertension. Hyporeninemic hypertension].
    Gutiérrez Millet V; Casado Pérez S; Ruilope Urioste LM; Hernando Avendaño L
    Rev Clin Esp; 1975 Apr; 137(2):105-14. PubMed ID: 1144838
    [No Abstract]   [Full Text] [Related]  

  • 24. Low-renin hypertension. Restoration of normotension and renin responsiveness.
    Spark RF; O'Hare CM; Regan RM
    Arch Intern Med; 1974 Feb; 133(2):205-11. PubMed ID: 4591266
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of furosemide stimulation on renin secretion and its application in examining activity of the renin-angiotensin system.
    Zofková I
    Cor Vasa; 1976; 18(4):304-9. PubMed ID: 1022409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Letter: Interpretation of low-renin profile.
    Modlinger RS; Gutkin M
    N Engl J Med; 1975 Jun; 292(25):1350-1. PubMed ID: 1128611
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evaluation of the plasma renin activity and urinary aldosterone excretion in patients with essential hypertension treated with spironolactone. Note II].
    Bompiani GD; Scaduto P; Galluzzo A; Donatelli M; Morici ML; Mangano MT; Messina L
    Minerva Cardioangiol; 1976 May; 24(5):352-9. PubMed ID: 1012481
    [No Abstract]   [Full Text] [Related]  

  • 28. Low renin hypertension and the adrenal cortex.
    Spark RF
    N Engl J Med; 1972 Aug; 287(7):343-9. PubMed ID: 4339423
    [No Abstract]   [Full Text] [Related]  

  • 29. [Spironolactone-induced changes of the renin-angiotensin-aldosterone system and blood pressure lowering in essential hypertension].
    Furrer J; Vetter W; Nussberger J; Beckerhoff R; Siegenthaler W
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():235-6. PubMed ID: 349929
    [No Abstract]   [Full Text] [Related]  

  • 30. [High-dose spironolactone therapy in essential hypertension patients with low plasma renin].
    Distler A; Keim HJ; Lommer D; Philipp T; Philippi A; Walter U; Wolff HP
    Verh Dtsch Ges Inn Med; 1973; 79():770-3. PubMed ID: 4789984
    [No Abstract]   [Full Text] [Related]  

  • 31. Spironolactone and hydrochlorothiazide in normal-renin and low-renin essential hypertension.
    Ferguson RK; Turek DM; Rovner DR
    Clin Pharmacol Ther; 1977 Jan; 21(1):62-9. PubMed ID: 318952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in patients with essential hypertension.
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):60-1. PubMed ID: 1071406
    [No Abstract]   [Full Text] [Related]  

  • 33. [Radioimmunological evaluation of plasma renin activity (PRA) in patients with hypertension in orthostatism and after stimulation with natriuretic agents].
    Cappelli G; Lamperi S
    Boll Soc Ital Biol Sper; 1976 Dec; 52(23):1985-90. PubMed ID: 1027471
    [No Abstract]   [Full Text] [Related]  

  • 34. [Longitudinal studies in essential hypertensive patients with low plasma renin activity].
    Esch I; Placheta P; Gaul G; Kneussel K
    Wien Klin Wochenschr; 1973 Sep; 85(38):617-21. PubMed ID: 4752255
    [No Abstract]   [Full Text] [Related]  

  • 35. Renin levels and spironolactone treatment in general practice: similar blood pressure lowering effect of spironolactone in low and normal renin patients.
    Sundsfjord JA; Odegaard AE
    Eur J Clin Invest; 1977 Oct; 7(5):389-92. PubMed ID: 411668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The multiple factors affecting plasma renin activity in essential hypertension.
    McDonald RH; Corder CN; Vagnucci AH; Shuman J
    Arch Intern Med; 1978 Apr; 138(4):557-61. PubMed ID: 637637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of pindolol (Visken) on blood pressure and plasma renin activity in various forms of hypertension].
    Werning C; Vetter H
    Adv Clin Pharmacol; 1976; 11():54-60. PubMed ID: 1032571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The value of studying essential arterial hypertension with isotopic methods. Their application in arterial hypertension with low renin level].
    Olmer M; Salvadori JM; Paulin R; Sommer A; Marion J
    Nouv Presse Med; 1974 Feb; 3(5):233-6. PubMed ID: 4819942
    [No Abstract]   [Full Text] [Related]  

  • 39. Angiotensin II blockade in normal man and patients with essential hypertension. Blood pressure effects depending on renin and sodium balance.
    Brunner HR; Gavras H; Ribeiro AB; Posternak L
    Prog Biochem Pharmacol; 1976; 12():145-62. PubMed ID: 1019161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renin concentrations and effects of propranolol and spironolactone in patients with hypertension.
    Karlberg BE; Kågedal B; Tegler L; Tolagen K
    Br Med J; 1976 Jan; 1(6004):251-4. PubMed ID: 764929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.